Curve Biosciences has filed a notice of an exempt offering of securities to raise $20,038,985.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Curve Biosciences is raising up to $20,038,985.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ritish Patnaik played a…